TLSA
Tiziana Life Sciences Ltd
1.10$
+2.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 99.4% | 99.0% | 99.9% | 63.3% | 99.3% | 99.7% | 91.7% | 60.2% | 66.5% | 74.4% | |
| 92.1% | 96.2% | 93.1% | 2.6% | 76.6% | 8.5% | 93.2% | 86.4% | 68.4% | 9.7% | 33.0% | 34.9% | |
| 92.1% | 96.2% | 93.1% | 2.6% | 76.6% | 8.5% | 93.2% | 86.4% | 68.4% | 9.7% | 33.0% | 34.9% | |
| 4.1% | 2.9% | 1.9% | 84.6% | 18.7% | 71.1% | 5.4% | 10.8% | 22.1% | 49.7% | 32.7% | 37.0% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -71.4% | 0.0% | -10.9% | -22.6% | – | – | – | |
| 0.0% | 0.0% | 0.6% | 1.3% | 0.1% | 24.3% | 0.5% | 0.0% | 1.5% | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | -0.1% | – | – | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.2% | 0.3% | – | – | – | – | |
| 27.8% | 8.1% | 34.4% | 191.9% | 92.5% | 331.2% | 11.7% | 15.5% | 26.1% | 54.6% | 65.1% | 99.5% | |
| 27.8% | 8.1% | 34.4% | 191.9% | 97.6% | 308.5% | 11.3% | 15.5% | 25.2% | 53.7% | 65.1% | 97.5% | |
| 8.4% | 2.3% | 4.5% | 12.8% | 4.5% | 48.6% | 3.3% | 2.8% | 0.5% | 1.1% | 0.9% | 1.9% | |
| 2.6% | 3.4% | 24.0% | 151.2% | 55.6% | 224.2% | 4.8% | 9.0% | 18.7% | 34.0% | 49.5% | 62.4% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 72.2% | 91.9% | 65.6% | -91.9% | 7.5% | -231.2% | 64.7% | 84.5% | 73.9% | 45.4% | 34.9% | 0.5% | |
| -145.8% | -132.3% | 218.5% | -1,625.1% | -731.6% | -2,386.4% | -119.8% | -221.3% | -439.1% | -1,097.1% | -1,283.5% | -386.4% | |
| 232.4% | 505.9% | 1,053.3% | 3,194.4% | 987.9% | 3,774.4% | 68.9% | 100.3% | 191.7% | 416.6% | 472.7% | 514.5% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.